• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Eko Unveils Newly Designed Heart Disease Detection App

by Fred Pennic 03/22/2022 Leave a Comment

Eko Unveils Newly Designed Heart Disease Detection App

What You Should Know:

– Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease. Heart disease is the leading cause of death in the U.S., and there has not been an efficient and affordable solution to screen for heart disease at the physical exam until now.

– Eko has transformed the traditional stethoscope into an intelligent disease detection tool to help clinicians spot cardiovascular disease easier during the physical exam. Their line of smart stethoscopes, when paired with its accompanying automated disease detection software using the Eko App, analyzes heart sounds with FDA-cleared and clinically proven AI algorithms.* In seconds, the algorithms can detect heart murmurs and atrial fibrillation (AFib)** with comparable performance to human experts.    


Clinically Validated Algorithms to Identify Heart Murmurs & Atrial Fibrillation

Eko’s AI algorithm to identify heart murmurs, a leading indicator of heart valve disease, was clinically validated to perform at a sensitivity of 87.6% and specificity of 87.8%. Their algorithm for detecting atrial fibrillation performed at a sensitivity of 98.9% and a specificity of 96.9%. Real-world validation of Eko’s heart murmur detection algorithm came from a recent, peer-reviewed publication in the Journal of the American Heart Association. It was the largest study on AI analysis of cardiac murmurs to date.

“Eko’s technology has given me the added assurance to detect and verify heart murmurs and atrial fibrillation in my patients,” said Joanna Kmiecik, MD, Family Medicine Specialist. “The ease-of-use and portable nature of Eko’s products helps me to examine patients right in my office, with minimal impact to my physical examination routine. If I hear a heart sound suspicious of disease, Eko accurately confirms it in seconds. This helps me to determine care decisions and refer to a specialist confidently when appropriate. My patients even enjoy how they can engage with the app, and I feel I am a better clinician.” 

Tagged With: AI, algorithms, American Heart Association, Atrial Fibrillation, digital health, Eko Devices, FDA, Heart, heart disease, lung, MD

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |